Publicaciones
Found(s) 20 result(s)
Found(s) 2 page(s)
Found(s) 2 page(s)
Production of reactive species in alginate hydrogels for cold atmospheric plasma-based therapies
UPCommons. Portal del coneixement obert de la UPC
- Labay, Cédric Pierre|||0000-0001-5147-5100
- Hamouda, Inés|||0000-0002-9842-4287
- Tampieri, Francesco|||0000-0003-1474-867X
- Ginebra Molins, Maria Pau|||0000-0002-4700-5621
- Canal Barnils, Cristina|||0000-0002-3039-7462
In the last years, great advances have been made in therapies based in cold atmospheric plasmas (CAP). CAP generate reactive oxygen and nitrogen species (RONS) which can be transferred to liquids. These CAP activated liquids display the same biological efficacy (i.e. on killing cancer cells) as CAP themselves, opening the door for minimally invasive therapies. However, injection of a liquid in the body results in fast diffusion due to extracellular fluids and blood flow. Therefore, the development of efficient vehicles which allow local confinement and delivery of RONS to the diseased site is a fundamental requirement. In this work, we investigate the generation of RONS (H2O2, NO2-, short-lived RONS) in alginate hydrogels by comparing two atmospheric pressure plasma jets: kINPen and a helium needle, at a range of plasma treatment conditions (time, gas flow, distance to the sample). The physic-chemical properties of the hydrogels remain unchanged by the plasma treatment, while the hydrogel shows several-fold larger capacity for generation of RONS than a typical isotonic saline solution. Part of the RONS are quickly released to a receptor media, so special attention has to be put on the design of hydrogels with in-situ crosslinking. Remarkably, the hydrogels show capacity for sustained release of the RONS. The plasma-treated hydrogels remain fully biocompatible (due the fact that the species generated by plasma are previously washed away), indicating that no cytotoxic modifications have occurred on the polymer. Moreover, the RONS generated in alginate solutions showed cytotoxic potential towards bone cancer cells. These results open the door for the use of hydrogel-based biomaterials in CAP-associated therapies., Peer Reviewed
Pyruvate plays a main role in the antitumoral selectivity of cold atmospheric plasma in osteosarcoma
UPCommons. Portal del coneixement obert de la UPC
- Tornin Cavielles, Juan|||0000-0002-7676-3958
- Mateu Sanz, Miguel|||0000-0001-5117-6071
- Rodríguez, Aida
- Labay, Cédric Pierre|||0000-0001-5147-5100
- Rodríguez, Rene
- Canal Barnils, Cristina|||0000-0002-3039-7462
Osteosarcoma (os) is the most common primary bone tumor but current therapies still have poor prognosis. Cold Atmospheric Plasma (CAP) and Plasma activated media (PAM) have shown potential to eliminate cancer cells in other tumors. It is thought that Reactive Oxygen and Nitrogen species (RONS) in PAM are key players but cell culture media composition alters treatment outcomes and data interpretation due to scavenging of certain RONS. In this work, an atmospheric pressure plasma jet was employed to obtain PAM in the presence or absence of pyruvate and used to treat the SaOS-2 (OS) cell line or hBM-MSC healthy cells. OS cells show higher sensitivity to PAM treatment than healthy cells, both in medium with and without pyruvate, activating apoptosis, DNA damage and deregulating cellular pathways mediated by c-JUN, AKT, AMPK or STAT3. In line with previous works, lack of pyruvate increases cytotoxic potential of PAM affecting cancer and healthy cells by increasing 10–100 times the concentration of H2o2 without altering that of nitrites and thus decreasing CAP anti-tumor selectivity. Suitable conditions for CAP anti-cancer selectivity can be obtained by modifying plasma process parameters (distance, flow, treatment time) to obtain adequate balance of the different RONS in cell culture media.
Generation of reactive species by plasma needle in different líquids
UPCommons. Portal del coneixement obert de la UPC
- Hamouda, Inés|||0000-0002-9842-4287
- Gouhier, Alix
- Labay, Cédric Pierre|||0000-0001-5147-5100
- Ginebra Molins, Maria Pau|||0000-0002-4700-5621
- Canal Barnils, Cristina|||0000-0002-3039-7462
Plasma jet selectivity on bone cancer cells and liquid-mediated effects
UPCommons. Portal del coneixement obert de la UPC
- Canal Barnils, Cristina|||0000-0002-3039-7462
- Humbert, Marjolaine
- Guillem Martí, Jordi|||0000-0003-0307-2221
- Ginebra Molins, Maria Pau|||0000-0002-4700-5621
Peer Reviewed
Selectively targeting tumorigenicity in osteosarcoma
UPCommons. Portal del coneixement obert de la UPC
- Tornin Cavielles, Juan|||0000-0002-7676-3958
- Mateu Sanz, Miguel|||0000-0001-5117-6071
- Rey, Verónica
- Murillo, Dzohara
- Huergo, Carmen
- Rodríguez, Aida
- Rodríguez, René
- Canal Barnils, Cristina|||0000-0002-3039-7462
Data associated with the study called "Selectively targeting tumorigenicity in osteosarcoma". Each file corresponds to the raw data of one of the figures of the paper
Plasma-conditioned liquids as anticancer therapies in vivo: current state and future directions
UPCommons. Portal del coneixement obert de la UPC
- Solé Martí, Xavier|||0000-0002-5544-2485
- Espona Noguera, Albert|||0000-0002-3681-030X
- Ginebra Molins, Maria Pau|||0000-0002-4700-5621
- Canal Barnils, Cristina|||0000-0002-3039-7462
Plasma-conditioned liquids (PCL) are gaining increasing attention in the medical field, especially in oncology, and translation to the clinics is advancing on a good path. This emerging technology involving cold plasmas has great potential as a therapeutic approach in cancer diseases, as PCL have been shown to selectively kill cancer cells by triggering apoptotic mechanisms without damaging healthy cells. In this context, PCL can be injected near the tumor or intratumorally, thereby allowing the treatment of malignant tumors located in internal organs that are not accessible for direct cold atmospheric plasma (CAP) treatment. Therefore, PCL constitutes a very interesting and minimally invasive alternative to direct CAP treatment in cancer therapy, avoiding surgeries and allowing multiple local administrations. As the field advances, it is progressively moving to the evaluation of the therapeutic effects of PCL in in vivo scenarios. Exciting developments are pushing forward the clinical translation of this novel therapy. However, there is still room for research, as the quantification and identification of reactive oxygen and nitrogen species (RONS) in in vivo conditions is not yet clarified, dosage regimens are highly variable among studies, and other more relevant in vivo models could be used. In this context, this work aims to present a critical review of the state of the field of PCL as anticancer agents applied in in vivo studies., Peer Reviewed
Important parameters in plasma jets for the production of RONS in liquids for plasma medicine: A brief review
UPCommons. Portal del coneixement obert de la UPC
- Khlyustova, Anna
- Labay, Cédric Pierre|||0000-0001-5147-5100
- Machala, Zdenko
- Ginebra Molins, Maria Pau|||0000-0002-4700-5621
- Canal Barnils, Cristina|||0000-0002-3039-7462
Reactive oxygen and nitrogen species (RONS) are among the key factors in plasma medicine. They are generated by atmospheric plasmas in biological fluids, living tissues and in a variety of liquids. This ability of plasmas to create a delicate mix of RONS in liquids has been used to design remote or indirect treatments for oncological therapy by treating biological fluids by plasmas and putting them in contact with the tumour. Documented effects include selective cancer cell toxicity, even though the exact mechanisms involved are still under investigation. However, the “right” dose for suitable therapeutical activity is crucial and still under debate. The wide variety of plasma sources hampers comparisons. This review focuses on atmospheric pressure plasma jets as the most studied plasma devices in plasma medicine and compiles the conditions employed to generate RONS in relevant liquids and the concentration ranges obtained. The concentrations of H2O2, NO2-, NO3- and short-lived oxygen species are compared critically to provide a useful overview for the reader, Peer Reviewed
Influence of process parameters in the generation of reactive oxygen and nitrogen species in cell culture media by atmospheric pressure plasma jet
UPCommons. Portal del coneixement obert de la UPC
- Canal Barnils, Cristina|||0000-0002-3039-7462
- Humbert, Marjolaine
- Guillem Martí, Jordi|||0000-0003-0307-2221
- Ginebra Molins, Maria Pau|||0000-0002-4700-5621
Influence of the composition of plasma-activated medium on osteosarcoma
UPCommons. Portal del coneixement obert de la UPC
- Canal Barnils, Cristina|||0000-0002-3039-7462
- Tornin Cavielles, Juan|||0000-0002-7676-3958
- Mateu, Miguel
- Hamouda, Inés|||0000-0002-9842-4287
- Labay, Cédric Pierre|||0000-0001-5147-5100
- Guillem Martí, Jordi|||0000-0003-0307-2221
- Ginebra Molins, Maria Pau|||0000-0002-4700-5621
Thermosensitive hydrogels to deliver reactive species generated by cold atmospheric plasma: a case study with methylcellulose
UPCommons. Portal del coneixement obert de la UPC
- Solé Martí, Xavier|||0000-0002-5544-2485
- Vilella, Tània
- Labay, Cédric Pierre|||0000-0001-5147-5100
- Tampieri, Francesco|||0000-0003-1474-867X
- Ginebra Molins, Maria Pau|||0000-0002-4700-5621
- Canal Barnils, Cristina|||0000-0002-3039-7462
Hydrogels have been recently proposed as suitable materials to generate reactive oxygen and nitrogen species (RONS) upon gas-plasma treatment, and postulated as promising alternatives to conventional cancer therapies. Acting as delivery vehicles that allow a controlled release of RONS to the diseased site, plasma-treated hydrogels can overcome some of the limitations presented by plasma-treated liquids in in vivo therapies. In this work, we optimized the composition of a methylcellulose (MC) hydrogel to confer it with the ability to form a gel at physiological temperatures while remaining in the liquid phase at room temperature to allow gas-plasma treatment with suitable formation of plasma-generated RONS. MC hydrogels demonstrated the capacity for generation, prolonged storage and release of RONS. This release induced cytotoxic effects on the osteosarcoma cancer cell line MG-63, reducing its cell viability in a dose-response manner. These promising results postulate plasma-treated thermosensitive hydrogels as good candidates to provide local anticancer therapies., Peer Reviewed